Treatment of mice with anti-KC antibodies significantly promoted the pathogenesis of TMEV-induced demyelinating disease and elevated viral loads in the CNS compared to control IgG-treated mice (Figure 3). This evidence concerns the gene CALCA and demyelinating disease.